Jeffery Williamson is a partner at CRC where he has had particular recent involvement in investments in Micromet, CRC, Juno and Jounce Therapeutics. Previously, Jeffery was in charge of life sciences direct investments at. Before CRC, Jeffery was a portfolio manager of the an Immunology Fund, a $3bn listed investment vehicle, investing in public and private healthcare companies worldwide. Previously, Jeffery was a member of the HealthCare corporate finance and M&A team at Goldman Sachs. Before joining Goldman, Jeffery helped co-found the healthcare investment activities at Juno Securities. Jeffery has a PhD in Molecular Biology, and a PhD in Biotechnology.